BNET Industries

Market Cap:$179.0M
Last Fiscal Year Sales:$350.3M
  • Public
  • US
Dow Jones Description

Generic & Private Label Prescription Drug Developer

Number of Employees 272
Contact Information

1150 Elijah Mccoy Dr

Detroit, Michigan 48202

www.caraco.com

3138718400

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Caraco Pharmaceutical Laboratories, Ltd. Markets Nicardipine Hydrochloride Injection

    11/18/09 - Product Announcement - View Story

  • Caraco Pharmaceutical Labs Launches Generic Of Acular Ophthalmic Solution - Quick Facts

    11/06/09 - Product Announcement - View Story

  • Sun Pharma reports Q2 2009-10 financials

    10/28/09 - Financial Announcement - View Story

  • Caraco Pharmaceutical Laboratories, Ltd. CPD Closes Asset Purchase Agreement with Forest Laboratories, Inc. FRX to...

    10/02/09 - Joint Venture / Alliance - View Story

  • Caraco, Forest close settlement deal on Lexapro

    10/02/09 - Merger / Acquisition - View Story

  • Caraco BOD member resigns

    9/24/09 - Board Member - Leaving - View Story

  • Caraco Pharmaceutical Laboratories Announces Resignation Of Georges Ugeux From Board - Quick Facts

    9/23/09 - Mgmt. Change Leaving - Other - View Story

  • Caraco Pharmaceuticals CEO steps down

    7/30/09 - Mgmt. Change Leaving - CEO - View Story

  • Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as Jitendra...

    7/28/09 - Mgmt. Change Entering - CEO - View Story

  • Sun Pharma Profit Drops 67%

    7/29/09 - Financial Announcement - View Story

  • Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Caraco Pharmaceutical Laboratories, Ltd., Announc

    7/18/09 - Merger / Acquisition - View Story

  • Caraco Pharmaceutical Laboratories, Ltd. CPD Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. FRX...

    7/11/09 - Joint Venture / Alliance - View Story

  • Sun Pharma Withdraws Sales Guidance on FDA Move

    6/27/09 - Financial Announcement - View Story

News & Analysis

caraco pharmaceutical laboratories, ltd. - All News and Analysis

Decision Makers

Name (plus bio) Position
Daniel Movens CEO
Jitendra Doshi CFO & COO
Robert Kurkiewicz Senior Vice President, Technical
Gurpartap Singh Vice President, Sales & Marketing
Daniel Barone Director, Technical
Derrick Mann Director, Regulatory Affairs
Jayesh Shah Director, Commercial
Kaushikkumar Gandhi Director, Manufacturing
Thomas Larkin Director, Marketing

Board of Directors

Name (plus bio) Position
Dilip Shanghvi Chairman
Georges L. Ugeux Board of Directors
John D. Crissman Board of Directors
Madhava Reddy Board of Directors
Shailesh Desai Board of Directors
Sudhir Valia Board of Directors
Timothy Manney Board of Directors

Organization Position Status
Caraco Pharmaceutical Laboratories, Ltd. CEO Current
Caraco Pharmaceutical Laboratories, Ltd. Board of Directors Current

Organization Position Status
Caraco Pharmaceutical Laboratories, Ltd. CFO & COO Current
Caraco Pharmaceutical Laboratories, Ltd. Board of Directors Current

Organization Position Status
Caraco Pharmaceutical Laboratories, Ltd. Senior Vice President, Technical Current

Organization Position Status
Caraco Pharmaceutical Laboratories, Ltd. Vice President, Sales & Marketing Current

Organization Position Status
Caraco Pharmaceutical Laboratories, Ltd. Director, Technical Current

Organization Position Status
Caraco Pharmaceutical Laboratories, Ltd. Director, Regulatory Affairs Current

Organization Position Status
Caraco Pharmaceutical Laboratories, Ltd. Director, Commercial Current

Organization Position Status
Caraco Pharmaceutical Laboratories, Ltd. Director, Manufacturing Current

Organization Position Status
Caraco Pharmaceutical Laboratories, Ltd. Director, Marketing Current

Organization Position Status
Caraco Pharmaceutical Laboratories, Ltd. Chairman Current

A lawyer and economist by training, Georges Ugeux has focused his entire 30 year career on the global dimensions of business, government and finance. He has a deep understanding of the cultural dimension of negotiations, networks and partnerships. Georges began his career in commercial banking at Societe Generale de Banque (now Fortis Bank), where he became the General Manager of the investment banking and trust division. He later served as Managing Director of Morgan Stanley's Mergers and Acquisitions department, as well as Group Finance Director at Societe Generale de Belgique, a Belgian conglomerate. In 1992, he became President and Managing Director of Kidder, Peabody Europe. He was also a member of the European Corporate Executive Council of General Electric. He was President of the European investment Fund, a public private partnership financing infrastructure and SME projects owned by the European Investment Bank, the European Community and 77 European banks. For seven years Georges immersed himself in the global equity markets by heading the International Group of the New York Stock Exchange, bringing over 300 non-US companies, valued at $ 2.7 trillion, to the US market. He is a frequent public speaker and educator on global issues (at the College of Europe in Bruges and Harvard Law School). Georges Ugeux holds a Doctorate in Law and is Licentiate in Economics from the Catholic University of Louvain. He chairs and sits on Boards of numerous transatlantic organizations.

Organization Position Status
Galileo Global Advisors LLC Chairman and CEO Current
NYSE Group, Inc. Group Executive Vice President Current
The Essec USA Current
Belgian-American Chamber of Commerce Board of Directors Current
British-American Business Inc. Director Current
Caraco Pharmaceutical Laboratories, Ltd. Board of Directors Current
Morgan Stanley Managing Director Former
European Investment Bank Former

Organization Position Status
Caraco Pharmaceutical Laboratories, Ltd. Board of Directors Current

Organization Position Status
Caraco Pharmaceutical Laboratories, Ltd. Board of Directors Current

Organization Position Status
Caraco Pharmaceutical Laboratories, Ltd. Board of Directors Current

Organization Position Status
Caraco Pharmaceutical Laboratories, Ltd. Board of Directors Current

Organization Position Status
Caraco Pharmaceutical Laboratories, Ltd. Board of Directors Current

Executive News

  • Caraco Pharmaceutical Laboratories, Ltd. Announces Reversal of Summary Judgment in Ultracet(R) ANDA Patent Litigation

    Pharma Live - 8/27/09 - View Story

  • Caraco Pharmaceutical Laboratories, Ltd. Announces Reversal of Summary Judgment in...

    Reuters - 8/27/09 - View Story

  • Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Imitrex Tablets

    Pharma Live - 8/16/09 - View Story

advertisement
     CPD $4.58 +0.41 (9.83% )
Average Volume 56,869
Shares Outstanding 39.09M
Market Cap 179.0M
Year High 7.35
Year Low 1.75
Earnings Per Share -0.02
P/E Ratio -229.00
Dividend N/A
Yield N/A
advertisement